Scroll to Top

Volume : III, Issue : II, March - 2013

THE POTENTIAL ADVANTAGES OF NANOTECHNOLOGY IN ANAPLASMOSIS THERAPEUTICS: PREPARATION OF OXYTETRACLINE-LOADED PMMA NANOPARTICLES FOR ORAL DELIVERY

PRAKASH. K. B , MADHUSUDHAN. B , BHAGYALAKSHMI.M , K. DWIVEDI , JITENDER MADAN AND PRABHAKAR. P

Published By : Laxmi Book Publication

Abstract :

In recent days, nanoparticles-based drug delivery systems have considerable potential for treatment of several infectious diseases. The concept of nanoscale devices has led to the development of biodegradable self-assembled nanoparticles being engineered for the targeted delivery of therapeutic molecules. Biodegradable nanoparticulate carriers have become the promising nanoscale drug delivery system. The aim of the present investigation was to formulate and characterize the Oxytetracycline-loaded polymeric nanoparticles. Oxytetracycline, an antianaplasmic agent, was encapsulated by the nanoprecipitation method using poly(methyl methacrylate). Zeetasizer, Atomic force microscope, differential scanning calorimetry and FTIR were used to characterize the nanoparticles. The average diameters of the nanoparticles ranged between 200-250nm and the zeta potential was -32 mV. The drug loading capacity and loading efficiency of nanoparticles varied between 33.7% - 72.2% and 44.5% - 76.0%. The release profiles exhibited a biphasic phenomenon indicating controlled release of drug. The investigation suggests that the resultant nanoparticles would promise to be a good candidate for oral administration.

Keywords :


Article :


Cite This Article :

PRAKASH. K. B , MADHUSUDHAN. B , BHAGYALAKSHMI.M , K. DWIVEDI , JITENDER MADAN AND PRABHAKAR. P, (2013). THE POTENTIAL ADVANTAGES OF NANOTECHNOLOGY IN ANAPLASMOSIS THERAPEUTICS: PREPARATION OF OXYTETRACLINE-LOADED PMMA NANOPARTICLES FOR ORAL DELIVERY. Indian Streams Research Journal, Vol. III, Issue. II, http://oldisrj.lbp.world/UploadedData/2154.pdf

References :

  1. Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N. and Benita, S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55: R1–R4
  2. Marchal-Heussler, L. H., Fessi, J.P., Devissaguet, M., Hoffman, P. and Maincent. 1992. Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, polylactic-co-glycolic acid, poly-epsilon-caprolacton, S.T.P.Pharma. Sci. 2: 98–104
  3. Muller, R.H. 1991. Charge determinations: Colloidal Carriers for Controlled Drug Delivery and Targeting. In: R.H. Muller (Ed.). Modification, Characterization and In Vivo, CRC Press, Boca Raton, FL, 57–97
  4. Kreuter, J., 1991. Nanoparticles based drug delivery systems. J. Controlled Release, 16: 169-176
  5. Kreuter, J., 1983a. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 14: 43- 58.
  6. Harmia, T., Speiser, P. and Kreuter, J. 1986. Optimisation of pilocarpine loading onto nanoparticles by sorption procedures. Int. J. Pharm. 54: 33-45.
  7. Mfiller, R.H., Lherm, C., Herbort, J., Blunk, T. and Couvreur, P. 1992. Alkylcyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different alkyl chain length. Int. J. Pharm. 84 (l): I 1
  8. Douglas, S.J., Davis, S.S. and Illum, L. 1987. Nano particles in drug delivery, CRC Crit, Rev. Ther. Drug carrier Syst. 3: 233-261

Article Post Production

Article Indexed In

Comments :

Enter Name :
Email ID :
Comments :

Previous Comments :

Creative Commons License
Indian Streams Research Journal by Laxmi Book Publication is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://oldisrj.lbp.world/Default.aspx.
Permissions beyond the scope of this license may be available at http://oldisrj.lbp.world/Default.aspx
Copyright � 2014 Indian Streams Research Journal. All rights reserved
Looking for information? Browse our FAQs, tour our sitemap, or contact ISRJ
Read our Privacy Policy Statement and Plagairism Policy. Use of this site signifies your agreement to the Terms of Use